SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/14/24 AVROBIO, Inc. S-4 91:25M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: S-4 Registration Statement - Securities for a Merger HTML 7.87M 2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 122K 3: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 126K 4: EX-10.21 Material Contract HTML 78K 5: EX-10.22 Material Contract HTML 32K 6: EX-10.41 Material Contract HTML 56K 7: EX-10.42 Material Contract HTML 109K 8: EX-10.43 Material Contract HTML 26K 9: EX-21.1 Subsidiaries List HTML 24K 10: EX-23.1 Consent of Expert or Counsel HTML 24K 11: EX-23.2 Consent of Expert or Counsel HTML 24K 13: EX-FILING FEES Filing Fees HTML 43K 12: EX-99.10 Miscellaneous Exhibit HTML 27K 19: R1 Cover HTML 60K 20: R2 Condensed Consolidated Balance Sheets HTML 122K 21: R3 Condensed Consolidated Balance Sheets HTML 46K (Parenthetical) 22: R4 Condensed Consolidated Statements of Operations HTML 81K and Comprehensive Income (Loss) 23: R5 Condensed Consolidated Statements of Stockholders' HTML 97K Equity 24: R6 Condensed Consolidated Statements of Stockholders' HTML 28K Equity (Parenthetical) 25: R7 Condensed Consolidated Statements of Cash Flows HTML 135K 26: R8 Nature of the Business HTML 40K 27: R9 Summary of Significant Accounting Policies HTML 84K 28: R10 License Agreements HTML 74K 29: R11 Fair Value Measurement HTML 65K 30: R12 Supplemental Balance Sheet Information HTML 91K 31: R13 Leases HTML 62K 32: R14 Commitments and Contingencies HTML 37K 33: R15 401(k) Savings Plan HTML 31K 34: R16 Note Payable HTML 52K 35: R17 Stockholders' Equity HTML 57K 36: R18 Stock-Based Compensation HTML 108K 37: R19 Income Taxes HTML 63K 38: R20 Net Income (Loss) Per Share HTML 59K 39: R21 Related Party Transactions HTML 35K 40: R22 Restructuring Activities HTML 38K 41: R23 Subsequent Events HTML 30K 42: R24 Summary of Significant Accounting Policies HTML 131K (Policies) 43: R25 Summary of Significant Accounting Policies HTML 30K (Tables) 44: R26 Fair Value Measurement (Tables) HTML 63K 45: R27 Supplemental Balance Sheet Information (Tables) HTML 95K 46: R28 Leases (Tables) HTML 59K 47: R29 Note Payable (Tables) HTML 40K 48: R30 Stockholders' Equity (Tables) HTML 49K 49: R31 Stock-Based Compensation (Tables) HTML 97K 50: R32 Income Taxes (Tables) HTML 58K 51: R33 Net Income (Loss) Per Share (Tables) HTML 60K 52: R34 Restructuring Activities (Tables) HTML 32K 53: R35 Nature of the Business - Additional Information HTML 42K (Detail) 54: R36 Summary of Significant Accounting Policies - HTML 45K Additional Information (Detail) 55: R37 Summary of Significant Accounting Policies - HTML 36K Schedule of Property and Equipment Estimated Useful Life (Detail) 56: R38 License Agreements - Additional Information HTML 120K (Detail) 57: R39 Fair Value Measurement - Summary of Financial HTML 36K Assets Measured at Fair Value on Recurring Basis (Detail) 58: R40 Supplemental Balance Sheet Information - Summary HTML 38K of Prepaid Expenses and Other Current Assets (Detail) 59: R41 Supplemental Balance Sheet Information - Summary HTML 50K of Property and Equipment, Net (Detail) 60: R42 Supplemental Balance Sheet Information - HTML 42K Additional Information (Detail) 61: R43 Supplemental Balance Sheet Information - Summary HTML 31K of Restricted Cash (Detail) 62: R44 Supplemental Balance Sheet Information - Summary HTML 36K of Accrued Expenses (Detail) 63: R45 Leases - Additional Information (Detail) HTML 64K 64: R46 Leases - Summary of effective lease cost HTML 31K comprehensive income loss (Detail) 65: R47 Leases - Summary of Future Minimum Payments of HTML 52K Operating Lease Liabilities (Detail) 66: R48 Lease - Schedule of Future Minimum Lease Payments HTML 40K for Capital Leases Relevant Accounting Standard (Detail) 67: R49 Note Payable - Additional Information (Detail) HTML 84K 68: R50 Note Payable - Carrying Value of Note Payable HTML 33K (Detail) 69: R51 Note Payable - Future Principal Payments (Detail) HTML 40K 70: R52 Stockholders' Equity - Additional Information HTML 77K (Detail) 71: R53 Stockholders' Equity - Summary of Common Stock HTML 47K Reserved for Future Issuance (Detail) 72: R54 Stock-Based Compensation - Summary of Assumptions HTML 36K that Used to Determine Grant-Date Fair Value of Stock Options Granted to Employees and Members of Board of Directors (Detail) 73: R55 Stock-Based Compensation - Summary of Stock Option HTML 63K Activity (Detail) 74: R56 Stock-Based Compensation - Additional Information HTML 94K (Detail) 75: R57 Stock-Based Compensation - Summary of Restricted HTML 56K Common Stock Units (Detail) 76: R58 Stock-Based Compensation - Schedule of Stock-based HTML 34K Compensation Expense (Detail) 77: R59 401(k) Savings Plan - Additional Information HTML 33K (Detail) 78: R60 Income Taxes - Additional Information (Detail) HTML 64K 79: R61 Income Taxes - Schedule of Reconciliation of HTML 45K Income Tax Expense (Benefit) (Detail) 80: R62 Income Taxes - Schedule of Deferred Tax Assets and HTML 57K Liabilities (Detail) 81: R63 Net Income (Loss) Per Share - Components of Basic HTML 56K and Diluted Earnings Per Share (Detail) 82: R64 Net Income (Loss) Per Share - Schedule of Dilutive HTML 40K Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share (Detail) 83: R65 Related Party Transactions - Additional HTML 47K Information (Detail) 84: R66 Restructuring Activities (Additional Information) HTML 46K (Details) 85: R67 Restructuring Activities - Summary of HTML 38K Restructuring Activities (Detail) 86: R68 Subsequent Events (Additional Information) HTML 31K (Details) 88: XML IDEA XML File -- Filing Summary XML 157K 91: XML XBRL Instance -- d770053ds4_htm XML 2.00M 87: EXCEL IDEA Workbook of Financial Report Info XLSX 168K 15: EX-101.CAL XBRL Calculations -- avro-20230930_cal XML 139K 16: EX-101.DEF XBRL Definitions -- avro-20230930_def XML 579K 17: EX-101.LAB XBRL Labels -- avro-20230930_lab XML 1.23M 18: EX-101.PRE XBRL Presentations -- avro-20230930_pre XML 893K 14: EX-101.SCH XBRL Schema -- avro-20230930 XSD 186K 89: JSON XBRL Instance as JSON Data -- MetaLinks 473± 703K 90: ZIP XBRL Zipped Folder -- 0001193125-24-034461-xbrl Zip 5.69M
EX-10.43 |
Exhibit 10.43
TECTONIC THERAPEUTIC, INC.
AMENDMENT TO 2019 EQUITY INCENTIVE PLAN
This Amendment to the Tectonic Therapeutic, Inc. 2019 Equity Incentive Plan (this “Amendment”) is dated March 31, 2021 and amends the Tectonic Therapeutic, Inc. 2019 Equity Incentive Plan (as amended to date, the “Plan”). Capitalized words used but not defined herein shall have the meaning given to them in the Plan.
1. The first sentence of Section 3(a)(i) of the Plan is amended and restated in its entirety to read as follows:
“Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Stock Awards from and after the Effective Date will not exceed 1,991,264 shares (the “Share Reserve”).”
2. Except as set forth in this Amendment, the Plan shall be unaffected hereby and remain in full force and effect.
[Remainder of page left intentionally blank]
IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its duly authorized officer as of the date set forth above.
TECTONIC THERAPEUTIC, INC. | ||
By: | /s/ Alise Reicin | |
Alise Reicin, CEO |
Signature Page to Tectonic Therapeutic, Inc. – Amendment to 2019 Equity Incentive Plan
This ‘S-4’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed as of: | 2/14/24 | |||
Filed on: | 2/13/24 | SC 13G/A | ||
3/31/21 | 10-Q | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/15/24 AVROBIO, Inc. S-4/A 91:17M Donnelley … Solutions/FA 3/26/24 AVROBIO, Inc. S-4/A 3/25/24 89:18M Donnelley … Solutions/FA 3/14/24 AVROBIO, Inc. 10-K 12/31/23 80:9.4M Donnelley … Solutions/FA |